Are NAD (Nicotinamide adenine dinucleotide) injections a recommended treatment for any medical condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NAD Injections: Not Recommended for Any Medical Condition

NAD (Nicotinamide adenine dinucleotide) injections are not recommended for any medical condition due to lack of clinical evidence supporting their use and absence of established guidelines recommending them for any specific medical condition. 1

Understanding NAD and Its Role

  • NAD+ is an essential coenzyme involved in over 400 enzymatic reactions in the body, including energy metabolism, DNA repair, and antioxidant effects 1
  • NAD+ levels naturally decline with age and in certain disease states, which has prompted interest in supplementation strategies 2
  • While NAD+ is crucial for cellular function, the specific delivery method of injectable NAD has not been validated in clinical guidelines 1

Current Evidence and Guidelines

  • No established clinical guidelines from major medical organizations recommend NAD injections for any medical condition 1
  • The American Academy of Physical Medicine and Rehabilitation does not endorse NAD injections due to insufficient clinical evidence 1
  • Recent systematic reviews have found limited high-quality clinical trials evaluating injectable NAD for specific conditions 3
  • Most research has focused on oral NAD precursors rather than direct injections 4, 2

Safety Concerns with NAD Injections

  • Injectable forms of NAD bypass normal digestive processes and may lead to unpredictable blood levels 5
  • High-dose nicotinamide (a form of vitamin B3 related to NAD) can cause adverse effects including:
    • Flushing, nausea, vomiting, and liver toxicity 1
    • Potential inhibition of poly(ADP-ribose) polymerases (PARPs), which protect genome integrity 5
    • Alterations in cellular methyl metabolism affecting DNA and protein methylation 5
  • Injection-related risks including infection, pain, and inflammation at injection sites 1

Appropriate Niacin Supplementation

  • For individuals requiring niacin supplementation, established guidelines recommend:
    • Enteral nutrition: 18-40 mg per day of niacin in 1500 kcal 6
    • Parenteral nutrition: at least 40 mg of niacin per day 6
  • Dietary sources of niacin (meat, poultry, fish, nuts, legumes) are the preferred method for maintaining adequate NAD+ levels 1
  • Upper intake levels have been established at:
    • 10 mg/day for nicotinic acid due to potential flushing effects 1
    • Approximately 900 mg/day for nicotinamide for adults 1

Alternative Approaches Being Studied

  • Oral NAD+ precursors (nicotinamide riboside and nicotinamide mononucleotide) have been more extensively studied than injections 4, 2
  • Clinical trials of oral NAD precursors have shown:
    • Safety and tolerability in humans 2
    • Ability to increase NAD+ levels in tissues 4
    • However, efficacy for specific health conditions remains less robust than suggested by preclinical studies 4, 2

Clinical Applications Under Investigation

  • Limited evidence suggests potential benefits of NAD-boosting compounds (not specifically injections) for:
    • Chronic fatigue syndrome - some improvement in quality of life and fatigue intensity 3
    • Muscle insulin sensitivity in specific populations 3
    • Psoriasis and enhancement of skeletal muscle activity (preliminary findings) 7
  • However, these findings remain preliminary and require larger, well-designed clinical trials before clinical recommendations can be made 7

References

Guideline

NAD Patches: Safety and Effectiveness for Medical Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.

The journals of gerontology. Series A, Biological sciences and medical sciences, 2023

Research

Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.

American journal of physiology. Endocrinology and metabolism, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Evidence for Targeting NAD Therapeutically.

Pharmaceuticals (Basel, Switzerland), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.